Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;8(1):31-38.
doi: 10.15171/bi.2018.05. Epub 2017 Nov 1.

Spectrophotometric analysis of thrombolytic activity: SATA assay

Masumeh Zamanlu  1 , Morteza Eskandani  2 , Reza Mohammadian  1 , Nazila Entekhabi  3 , Mohammad Rafi  4 , Mehdi Farhoudi  1
Affiliations

Spectrophotometric analysis of thrombolytic activity: SATA assay

Masumeh Zamanlu et al. Bioimpacts. 2018.

Abstract

Introduction: Measurement of thrombolytic activity is crucial for research and development of novel thrombolytics. It is a key factor in the assessment of the effectiveness of conventionally used thrombolytic therapies in the clinic. Previous methods used for the assessment of thrombolytic activity are often associated with some drawbacks such as being costly, time-consuming, complex with low accuracy. Here, we introduce a simple, economic, relatively accurate and fast method of spectrophotometric analysis of thrombolytic activity (SATA) assay, standardized by tissue plasminogen activator (tPA), which can quantitatively measure in vitro thrombolytic activity. Methods: Blood clots were formed, uniformly, by mixing citrated whole blood with partial thromboplastin time (PTT) reagent, together with calcium chloride. Then, designated concentrations of tPA were added to the samples, and the released red blood cells from each clot were quantified using spectrophotometry (λmax=405nm) as an indicator of thrombolytic activity. The accuracy of the method was tested by assessment of dose-responsibility against R2 value obtained by linear equation and measurement of the limit of detection (LOD) and limit of quantification (LOQ). The SATA assay was validated in comparison with some currently used techniques. Results: A linear relationship was obtained between different concentrations of tPA versus the spectrophotometric absorbance of the related dilutions of lysed clots, at λmax=405nm. Calculated R2 values were greater than 0.9; with LOD of 0.90 µg/mL of tPA (436.50IU) and LOQ of 2.99 µg/mL of tPA (1450.15IU). Conclusion: Conclusively, the SATA assay is a very simple quantitative method with repeatable and reproducible results for estimating the potency of an unknown thrombolytic agent, and calculating the activity as delicate as 1 µg/mL of tPA (485 IU/mL of thrombolytic dose).

Keywords: Clot lysis; Fibrinolysis; In vitro thrombolysis; Thrombolytic agent; Thrombolytic therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fig. 2
Fig. 2
Fig. 3
Fig. 3
Fig. 4
Fig. 4
Fig. 5
Fig. 5
Fig. 6
Fig. 6
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612–23. doi: 10.1016/s0140-6736(08)60694-7. - DOI - PubMed
    1. Verstraete M, Bernard R, Bory M, Brower RW, Collen D, de Bono DP. et al. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985;1:842–7. doi: 10.1016/S0140-6736(85)92208-1. - DOI - PubMed
    1. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL. et al. Recombinant tissue plasminogen activator for acute ischaemic stroke:an updated systematic review and meta-analysis. Lancet. 2012;379:2364–72. doi: 10.1016/s0140-6736(12)60738-7. - DOI - PMC - PubMed
    1. Collen D, Bounameaux H. Coronary thrombolysis with clot-selective plasminogen activators. Herz. 1986;11:9–15. - PubMed
    1. Collen D, Gold HK. New developments in thrombolytic therapy. Adv Exp Med Biol. 1990;281:333–54. doi: 10.1016/0049-3848(90)90384-O. - DOI - PubMed

LinkOut - more resources